Psilocybin Microdosing: Trends, Research, and Legal Landscape in the USA

The growing interest in US psilocybin microdose capsules reflects a shift in treatment paradigms.

The standard microdose ranges between 0.1 mg to 0.3 mg of pure psilocybin, well under the normal dose of psilocybin used in clinical trials.

Latest research suggest microdose psilocybin for depression, with many US patients reporting improved mood.

Is psilocybin legal in the US? The answer varies, with Maryland and certain US jurisdictions moving psilocybin is it legal toward regulated access.

Side effects of microdosing psilocybin are typically low, including temporary anxiety.
Academic papers show differences across mushroom types.
Psilocybin clinical trials Canada provide additional insight on therapeutic outcomes.

News psilocybin this week underscore that psilocybin therapy micro dose is becoming mainstream across the US.

PSILOCYBIN MICRODOSING: TRENDS, RESEARCH, AND LEGAL LANDSCAPE IN THE USA